Erythropoietin for patients with malignant disease
Información
- DOI:
- https://doi.org/10.1002/14651858.CD003407.pub3Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 19 octubre 2005see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Hematología
- Copyright:
-
- Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
JULIA BOHLIUS: Protocol development, searching for trials, eligibility and quality assessment, data extraction and analysis, drafting of final review
SIMON LANGENSIEPEN: Protocol development, searching, selection of studies, eligibility and quality assessment, data extraction and analysis, drafting of final review
GUIDO SCHWARZER: Statistical and methological advice, data analysis, content input
JEROME SEIDENFELD: Elegibility and quality assessment, data analysis, clinical and scientific advice, content input
MARGARET PIPER: Elegibility and quality assessment, data analysis, clinical and scientific advice, content input
CHARLES BENNETT: Clinical and scientific advice, content input
ANDREAS ENGERT: Clinical and scientific advice, content input
Sources of support
Internal sources
-
Department of Internal Medicine I, University of Cologne, Germany.
-
Cochrane Haematological Malignancies Group (CHMG), Germany.
-
Agency for Healthcare Research and Quality (AHRQ), USA.
-
German Cochrane Centre, Germany.
External sources
-
No sources of support supplied
Declarations of interest
Julia Bohlius was invited by Amgen to attend a symposium. Simon Langensiepen and Guido Schwarzer: potential conflict of interest not known. Jerome Seidenfeld and Margaret Piper are employed by a membership association of health plans. Charles Bennett received research grants and served as a consultant for Amgen (Thousand Oaks, CA), Ortho‐Biotech (Raritan, NJ), Roche and Johnson & Johnson. Andreas Engert received research grants for other projects from Amgen, OrthoBiotech and Roche and has served as a part‐time consultant for OrthoBiotech.
Acknowledgements
We thank all authors and co‐workers of primary studies, for which additional information and study data were provided: R. Abels, K. Aziz, J. Blohmer, D. Case, S. Casinu, M. Cazzola, C. Coiffier, F. Dammacco, L. Del Mastro, D. Henry, Italian Cooperative Study Group, C. Kurz, T. Littlewood, V. Moebus, C. Oberhoff, A. Österborg, E. Rose, W. Ten Bokkel, N. Thatcher, JA. Thompson, NA.Throuvalas, A. Varan. We thank the pharmaceutical companies for providing us with data for various studies (Roche) and admitted additionally insight into their clinical study reports (OrthoBiotech).
Special thanks to the CHMG editors, affiliated consumers and members of the CHMG editorial base for critical advice and strong support: Lia Alewijnse‐Poelman, Benjamin Djulbegovic, Céline Fournier, Axel Glasmacher, Alexander Greb, Gail Higgins, Sabine Kluge, Thilo Kober, Maryann Napoli, Lena Specht, Ralph Meyer, Sue Richards, Nicole Skoetz, Sven Trelle, Olaf Weingart, Keith Wheatley. Furthermore, we thank all participants of the CHMG consumer workshop, held in Cologne from 30.4 ‐ 1.5.2004, who provided constructive comments towards the improvement of the final manuscript.
The editorial base of the Cochrane Haematological Malignancies Group is funded, as part of the Competence Network Malignant Lymphomas, by the German Ministry of Education and Research (BMBF).
Version history
| Published | Title | Stage | Authors | Version |
| 2012 Dec 12 | Erythropoietin or darbepoetin for patients with cancer | Review | Thomy Tonia, Annette Mettler, Nadège Robert, Guido Schwarzer, Jerome Seidenfeld, Olaf Weingart, Chris Hyde, Andreas Engert, Julia Bohlius | |
| 2006 Jul 19 | Erythropoietin or Darbepoetin for patients with cancer | Review | Julia Bohlius, Jayne Wilson, Jerome Seidenfeld, Margret Piper, Guido Schwarzer, Josie Sandercock, Sven Trelle, Olaf Weingart, Susan Bayliss, Susan Brunskill, Benjamin Djulbegovic, Charles Bennett, Simon Langensiepen, Chris Hyde, Andreas Engert | |
| 2005 Oct 19 | Erythropoietin for patients with malignant disease | Review | Julia Bohlius, Simon Langensiepen, Guido Schwarzer, Jerome Seidenfeld, Margret Piper, C Bennet, Andreas Engert, Charles Bennett | |
| 2004 Jul 19 | Erythropoietin for patients with malignant disease | Review | Julia JB Bohlius, Simon Langensiepen, Guido Schwarzer, J Seidenfeld, Margret Piper, C Bennet, Andreas Engert, Charles Bennett | |
| 2002 Apr 22 | Erythropoietin for patients with malignant disease | Protocol | Simon SL Langensiepen, Julia Bohlius, Jerome Seidenfeld, Margret Piper, C Bennett, Guido Schwarzer, Andreas Engert, Charles Bennet | |
